methionine sulfoximine has been researched along with carboplatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, YS; Kang, JH; Kim, DJ; Kim, HK; Lee, KS; Moon, HS; Park, JG | 1 |
| de Vries, EG; Meersma, GJ; Meijer, C; Mulder, NH; Sluiter, WJ; Timmer-Bosscha, H | 1 |
| Alken, PM; Forster, S; Koessig, J; Mickisch, GH; Roehrich, K; Tschada, RK | 1 |
| Brooks, SE; Dupuis, NP; Holden, SA; Korbut, TT; Teicher, BA | 1 |
| Backes, MG; Blanock, K; Emerson, EO; Jani, JP; Rihn, C; Scalamogna, D; Singh, SV; Specht, S; Stemmler, N; Xu, BH | 1 |
| Harrap, KR; Kelland, LR; Loh, SY; Mistry, P | 1 |
6 other study(ies) available for methionine sulfoximine and carboplatin
| Article | Year |
|---|---|
Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Female; Glutathione; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Stomach Neoplasms; Tumor Cells, Cultured | 1992 |
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Cisplatin; Cyclobutanes; Drug Resistance; Glutathione; Humans; Methionine Sulfoximine; Organoplatinum Compounds; Tumor Cells, Cultured | 1992 |
Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
Topics: Antimetabolites; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Carboplatin; Carcinoma, Renal Cell; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Glutathione; Humans; In Vitro Techniques; Kidney Neoplasms; Membrane Glycoproteins; Methionine Sulfoximine; Neoplasm Proteins; Organoplatinum Compounds; Oxidation-Reduction; Verapamil; Vinblastine | 1990 |
Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buthionine Sulfoximine; Carboplatin; Cisplatin; Drug Resistance; Etanidazole; Female; Humans; Methionine Sulfoximine; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1995 |
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Buthionine Sulfoximine; Cadmium; Cadmium Chloride; Carboplatin; Cell Line; Cell Survival; Chlorides; Cisplatin; Drug Resistance; Gene Expression; Glutathione; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Metallothionein; Methionine Sulfoximine; Mitomycin; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Buthionine Sulfoximine; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Culture Media; Drug Resistance; Female; Glutathione; Humans; Kinetics; Methionine Sulfoximine; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1993 |